I am an epidemiologist, currently funded by GlaxoSmithKline. I initially studied physiology at BSc and PhD level in Manchester. Since then, I spent several years at the UK Medicines & Healthcare Products Regulatory Agency and in the pharmaceutical industry investigating adverse effects of drugs - both in clinical trials and post-marketing. I completed the MSc in epidemiology at LSHTM in 2005.
Affiliations
Centres
Teaching
Most of my teaching is split between the LSHTM pharmacoepidemiology range of short courses and the MSc in Epidemiology,
Research
I am interested in pharmacoepidemiology, and in particular, how large electronic health record databases can be used to investigate the effects of drugs - both harmful and beneficial. I am exploring methodologies to minimize some of the biases inherent in the research of drug effects, and my main current areas of interest include case-only approaches to study design, the use of non-interventional data to estimate intended treatment effects, quantitative bias analysis, and the application of high dimensional propensity scores in electronic health data.